Multiple mechanisms in hepatic microsomal azoreduction

References

• Autrup H., Warwick G.P. Some characteristics of two azoreductase systems in rat liver. Relevance to the activity of 2-[4′-di(2′-bromylpropyl)-aminophenylazo] benzoic acid (CB10–252), a compound possessing cytotoxic activity. Chemico-Biological Interactions 1975; 11: 329–342
   PubMed Web of Science ®Google Scholar
• Aylward G.H., Garnett J.L., Sharp J.H. Alternating and direct current polarography of azobenzene in indifferent electrolyte in dimethylformamide. Analytical Chemistry 1967; 39: 457–460
   Web of Science ®Google Scholar
• Barek J., Hrncir R. Analysis of chemical carcinogens. IV. Polarographic and voltametric determination of 4-dimethylaminoazobenzene. Collection of Czechoslovak Chemical Communications 1986; 51: 2083–2090
   Google Scholar
• Boto K.G., Thomas F.G. The polarography of some substituted azobenzenes in acetonitrile. III. The effect of some strong proton donors. Australian Journal of Chemistry 1973; 25: 1669–1682
   Google Scholar
• Bray H.G., Clowes R.C., Thorpe W.V. The metabolism of azobenzene and p-hydroxyazobenzene in the rabbit. Biochemical Journal 1951; 49, lxv
   Google Scholar
• Combes R.D., Haveland-Smith R.B. A review of the genotoxicity of food, drug, and cosmetic colours and other azo, triphenylmethane and xanthene dyes. Mutation Research 1982; 98: 101–248
   PubMed Web of Science ®Google Scholar
• Corke C.T., Bunce N.J., Beaumont A., Merrick R.L. Diazonium cations as intermediates in the microbial transformation of chloroaniline to chlorinated biphenyls, azo compounds and triazines. Journal of Agricultural and Food Chemistry 1979; 27: 644–646
   Web of Science ®Google Scholar
• De-Araujo P.S., De-Andrade-Silva E., Raw I. Effect of drugs and hormones on rat liver dimethylaminoazobenzene activity. Brazilian Journal of Medical and Biological Research 1982; 15: 17–28
   PubMed Web of Science ®Google Scholar
• Elliott B.M. Azoreductase activity of Sprague Dawley and Wistar-derived rats towards both carcinogenic and non-carcinogenic analogues of 4-dimethylaminoazobenzene (DAB). Carcinogenesis 1984; 5: 1051–1055
   PubMed Web of Science ®Google Scholar
• Elson L.A., Warren F.L. The metabolism of azo compounds. I. Azobenzene. Biochemical Journal 1944; 38: 217–220
   PubMedGoogle Scholar
• Fouts J., Kamm J.J., Brodie B.B. Enzymatic reduction of prontosil and other azo dyes. Journal of Pharmacology and Experimental Therapeutics 1957; 120: 291–300
   PubMed Web of Science ®Google Scholar
• Fujita S., Okada Y., Peisach J. Inhibition of azoreductase activity by antibodies against cytochrome P-450 and P-448. Biochemical and Biophysical Research Communications 1981; 102: 492–498
   PubMed Web of Science ®Google Scholar
• Fujita S., Peisach J. Liver microsomal cytochromes P-450 and azoreductase activity. Journal of Biological Chemistry 1978; 253: 4512–4513
   PubMed Web of Science ®Google Scholar
• Fujita S., Peisach J. The stimulation of microsomal azoreduction by flavins. Biochimica Biophysica Acta 1982; 719: 178–189
   PubMed Web of Science ®Google Scholar
• Garner R.C., Martin C.N., Clayson D.B. Carcinogenic aromatic amines and related compounds. Chemical Carcinogens, C.E. Searle. American Chemical Society, Washington 1984; Vol. 1: 175–276
   Google Scholar
• Gibson G.D., Orton T.C., Tamburini P.P. Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). Biochemical Journal 1982; 203: 161–168
   PubMed Web of Science ®Google Scholar
• Guengerich F.P. Oxidation-reduction properties of rat liver cytochrome P-450 and NADPH-cytochrome P-450 reductase related to catalysis in reconstituted systems. Biochemistry 1983; 22: 2811–2820
   PubMed Web of Science ®Google Scholar
• Guengerich F.P., Ballou O.P., Coon M.J. Purified liver microsomal cytochrome P-450. Electron-accepting properties and oxidation-reduction potential. Journal of Biological Chemistry 1975; 250: 7405–7414
   PubMed Web of Science ®Google Scholar
• Hernandez P.H., Gillette J.R., Mazel P. Studies on the mechanism of mammalian hepatic azoreductase. I. Azoreductase activity of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase. Biochemical Pharmacology 1967a; 16: 1859–1875
   PubMed Web of Science ®Google Scholar
• Hernandez P.H., Mazel P., Gillette J.R. Studies on the mechanism of action of mammalian hepatic reductase. II. The effect of phenobarbital and 3-methylcholanthrene on carbon monoxide sensitive and insensitive azoreductase activities. Biochemical Pharmacology 1967b; 16: 1877–1888
   PubMed Web of Science ®Google Scholar
• IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man: Some Aromatic Azo Compounds. International Agency for Research on Cancer, Lyon 1975; Vol. 8
   Google Scholar
• Iyanagi T., Makino R., Anan F.F. Studies on the microsomal mixed-function oxidase system. Mechanism of action of hepatic NADPH-cytochrome P-450 reductase. Biochemistry 1981; 20: 1722–1730
   PubMed Web of Science ®Google Scholar
• Juchau M.R., Krasner J., Yaffe S.J. Studies on reduction of azo linkages in human placental homogenates. Biochemical Pharmacology 1968; 17: 1969–1979
   PubMed Web of Science ®Google Scholar
• Krygowski T.M., Tomasik P. Structure effects in pi-electron compounds. I. HMO-EIP (Hueckel Molecular Orbital-Effective Inductive Parameter) interpretation of substituted effects in polarography of some aromatic nitro- and axo-compounds. Bulletin de l'Academic Polonaise des Sciences, Serie des Sciences Chimiques 1970; 18: 303–308
   Google Scholar
• Lambooy J.P., Koffman B.M. 4-Dimethylaminoazobenzene: Carcinogenicities and reductive cleavage by microsomal azo reductase. Chemico-Biological Interations 1985; 53: 107–120
   PubMed Web of Science ®Google Scholar
• Levine W.G. Metabolism of azo dyes: Implication for detoxication and activation. Drug Metabolism Reviews 1991; 23: 253–309
   PubMed Web of Science ®Google Scholar
• Levine W.G. Azoreduction of drugs and other xenobiotics. Progress in Drug Metabolism 1992; 13: 179–216
   Google Scholar
• Levine W.G., Raza H. Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN. Drug Metabolism and Disposition 1988; 16: 441–448
   PubMed Web of Science ®Google Scholar
• Mallett A.K., King L.W., Walker R. Solubilization, purification and reconstitution of hepatic microsomal azoreductase activity. Biochemical Pharmacology 1985; 34: 337–342
   PubMed Web of Science ®Google Scholar
• Mason R.P., Peterson F.J., Holtzman J.L. Inhibition of azoreductase by oxygen. The role of the azo anion free radical metabolite in the reduction of oxygen to superoxide. Molecular Pharmacology 1978; 14: 665–671
   PubMed Web of Science ®Google Scholar
• Mueller G.C., Miller J.A. The reductive cleavage of 4-dimethylaminoazobenzene by rat liver: the intracellular distribution of the enzyme system and its requirement for triphospho-pyridine nucleotides. Journal of Biological Chemistry 1949; 180: 1125–1136
   PubMed Web of Science ®Google Scholar
• Mueller G.C., Miller J.A. The reductive cleavage of 4-dimethylaminoazobenzene by rat liver: reactivation of carbon dioxide-treated homogenates by riboflavin-adenine dinucleotide. Journal of Biological Chemistry 1950; 185: 145–154
   PubMed Web of Science ®Google Scholar
• Orton T.C., Parker G.L. The effect of hypolipidemic agents on the hepatic microsomal drug metabolizing system. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid. Drug Metabolism and Disposition 1982; 10: 110–115
   PubMed Web of Science ®Google Scholar
• Peterson F.J., Holtzman J.L., Crankshaw D., Mason R.M. Two sites of azoreduction in the monooxygenase system. Molecular Pharmacology 1988; 34: 597–603
   PubMed Web of Science ®Google Scholar
• Raza H., Levine W.G. Azo reduction of N, N-dimethyl-4-aminoazobenzene by rat liver microsomes. Selective induction by clofibrate. Drug Metabolism and Disposition 1986; 14: 19–24
   PubMed Web of Science ®Google Scholar
• Raza H., Levine W.G. Effect of hypolipidemic drugs on the metabolism of lauric acid and dimethylaminoazobenzene by rat liver microsomes. Biochemical Pharmacology 1987; 36: 774–778
   PubMed Web of Science ®Google Scholar
• Reich N.O., De Montellano Ortiz P. Dissociation of increased lauric acid α-hydroxylase from the antihyperlipidemic action of clofibrate. Biochemical Pharmacology 1986; 35: 1227–1233
   PubMed Web of Science ®Google Scholar
• Sadler J.L., Bard A.J. The electrochemical reduction of aromatic azo compounds. Journal of the American Chemical Society 1968; 90: 1979–1989
   Web of Science ®Google Scholar
• Stoddart A.M., Levine W.G. Azoreduction of dimethylaminoazobenzene (DAB) in primary cultures of rat hepatocytes. Effect of hypolipidemic agents. Drug Metabolism and Disposition 1990; 18: 36–41
   PubMed Web of Science ®Google Scholar
• Tamburini P.P., Masson H.A., Bains S.K., Makowski R.J., Morris B., Gibson G.G. Multiple forms of hepatic cytochrome P-450. Purification, characterization and comparison of a novel clofibrate-induced isozyme with other major forms of cytochrome P-450. European Journal of Biochemistry 1984; 139: 235–246
   PubMedGoogle Scholar
• Trefouel J., Trefouel J., Nitti F., Bovet D. Activite du p-aminophenylsulfamide sur les infections streptococciques. Experimentales de la souris et du lapin. Comptes Rendus des Seances de la Societe de Biologie 1935; 120: 756–762
   Google Scholar
• Waterman M.R., Mason H.S. Redox properties of liver cytochrome P-450. Archives of Biochemistry and Biophysics 1972; 150: 57–63
   PubMed Web of Science ®Google Scholar
• Zbaida S., Levine W.G. Characteristics of two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P-450. Biochemical Pharmacology 1990; 40: 2415–2423
   PubMed Web of Science ®Google Scholar
• Zbaida S., Levine W.G. A novel application of cyclic voltammetry for direct investigation of metabolic intermediates in microsomal azo reduction. Chemical Research in Toxicology 1991; 4: 82–88
   PubMed Web of Science ®Google Scholar
• Zbaida S., Stoddart A., Levine W.G. Studies on the mechanism of reduction of azo dye carcinogens by rat liver microsomal cytochrome P-450. Chemico-Biological Interactions 1989; 69: 61–71
   PubMed Web of Science ®Google Scholar